Sonora Investment Management’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Sonora Investment Management’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$9K	Hold	200	–	–	﹤0.01%	807
2021 Q2	$10K	Buy	+200	New	+$10K	﹤0.01%	721

Other funds holding XPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

HCIA

Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Sonora Investment Management's XPH Position: Q3 2021 in Review

Sonora Investment Management held its State Street SPDR S&P Pharmaceuticals ETF (XPH) position steady in Q3 2021 at 200 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #807.

Sonora Investment Management first reported a position in XPH in Q2 2021 and has held it in 2 quarters since. The position peaked at $10K in Q2 2021. 78 funds tracked by Wall St. Rank hold XPH as of Q3 2021.

Sonora Investment Management held 200 shares of State Street SPDR S&P Pharmaceuticals ETF worth $9K as of Q3 2021.
Sonora Investment Management left its State Street SPDR S&P Pharmaceuticals ETF share count unchanged in Q3 2021.
State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Sonora Investment Management's portfolio in Q3 2021, its #807 holding.
Sonora Investment Management first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2021 and has held it in 2 quarters since.
Sonora Investment Management's State Street SPDR S&P Pharmaceuticals ETF position peaked at $10K in Q2 2021.
78 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2021.

Based on Sonora Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.